A targeted therapy for stroke
Stroke occurs when there is a block in the blood supply to a part of the brain. It affects more than one million people every year, and emergency treatments usually involve medication to resolve the blood clots that caused the stroke. Stroke care then on focuses on recovering as much of movement and sensation as possible through rehabilitation. Funded by the Marie Skłodowska-Curie Actions programme, the NeuProHRI project aims to develop a novel therapy for stroke that targets the heme regulated inhibitory (HRI) kinase cellular cascade. Researchers will employ different models of stroke to investigate the pathways that are activated by HRI kinase and test the outcome of compounds on the phenotype of stroke.
Fields of science
- HORIZON.1.2 - Marie Skłodowska-Curie Actions (MSCA) Main Programme
Funding SchemeHORIZON-AG-UN - HORIZON Unit Grant
See on map